BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3277544)

  • 1. Persistent subepidermal blistering in split-thickness skin graft sites. Ultrastructural and antigenic features simulating dystrophic or immunofluorescence-negative acquired epidermolysis bullosa.
    Epstein A; Hendrick SJ; Sanchez RL; Solomon AR; Fine JD
    Arch Dermatol; 1988 Feb; 124(2):244-9. PubMed ID: 3277544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient intraepidermal bullous reaction after skin graft for toxic epidermal necrolysis. Ultrastructural and immunohistochemical features similar to those of inherited epidermolysis bullosa simplex.
    Bourgault I; Prost C; André C; Villada G; Wechsler J; Chosidow O; Revuz J
    Arch Dermatol; 1991 Sep; 127(9):1369-74. PubMed ID: 1892406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
    Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
    Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa.
    Shimizu H; Sato M; Ban M; Kitajima Y; Ishizaki S; Harada T; Bruckner-Tuderman L; Fine JD; Burgeson R; Kon A; McGrath JA; Christiano AM; Uitto J; Nishikawa T
    Arch Dermatol; 1997 Sep; 133(9):1111-7. PubMed ID: 9301588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidermolysis bullosa acquisita--manifestations in otorhinolaryngology].
    Schenk P; Konrad K
    Laryngol Rhinol Otol (Stuttg); 1983 Oct; 62(10):456-62. PubMed ID: 6358736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment].
    Hintner H; Schuler G; Fritsch P
    Hautarzt; 1982 Jun; 33(6):310-4. PubMed ID: 6179897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basement membrane and fibroblast aberration in blisters at the donor, graft, and spontaneously healed sites in patients with burns.
    Chetty BV; Boissy RE; Warden GD; Nordlund JJ
    Arch Dermatol; 1992 Feb; 128(2):181-6. PubMed ID: 1739295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features.
    Woodley DT; Gammon WR
    Cutis; 1983 Dec; 32(6):521-7. PubMed ID: 6357643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.
    Rubenstein R; Esterly NB; Fine JD
    Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acquired epidermolysis bullosa. A clinico-pathologic study].
    Rappersberger K; Konrad K; Schenk P; Tappeiner G
    Hautarzt; 1988 Jun; 39(6):355-62. PubMed ID: 3042704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs.
    Stewart MI; Woodley DT; Briggaman RA
    Arch Dermatol; 1991 Mar; 127(3):373-7. PubMed ID: 1998368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolysis bullosa acquisita with negative direct immunofluorescence.
    Lacour JP; Juhlin L; el Baze P; Ortonne JP
    Arch Dermatol; 1985 Sep; 121(9):1183-5. PubMed ID: 3899018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis by electron microscopy of recessive dystrophic epidermolysis bullosa].
    Glorio RR; Solari A; Woscoff A
    Medicina (B Aires); 2000; 60(3):354-6. PubMed ID: 11050816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional distribution of basement membrane components in dystrophic recessive epidermolysis bullosa.
    Muda AO; Paradisi M; Angelo C; Puddu P; Faraggiana T
    J Pathol; 1996 Aug; 179(4):427-31. PubMed ID: 8869292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidermolysis bullosa].
    García Pérez A
    An R Acad Nac Med (Madr); 1999; 116(2):387-413; discussion 413-5. PubMed ID: 10682398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural findings in epidermolysis bullosa.
    Smith LT
    Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
    Vodegel RM; Jonkman MF; Pas HH; de Jong MC
    Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
    Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
    Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.